Search Results - "Yancopoulos, G D"

Refine Results
  1. 1
  2. 2

    Delta-Like Ligand 4 (Dll4) Is Induced by VEGF as a Negative Regulator of Angiogenic Sprouting by Lobov, I. B., Renard, R. A., Papadopoulos, N., Gale, N. W., Thurston, G., Yancopoulos, G. D., Wiegand, S. J.

    “…Genetic deletion studies have shown that haploinsufficiency of Delta-like ligand (Dll) 4, a transmembrane ligand for the Notch family of receptors, results in…”
    Get full text
    Journal Article
  3. 3

    Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1 by Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., McDonald, D. M.

    “…Angiopoietin-1 (Ang1) and vascular endothelial growth factor (VEGF) are endothelial cell-specific growth factors. Direct comparison of transgenic mice…”
    Get full text
    Journal Article
  4. 4

    Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF by Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., Wiegand, S. J.

    “…In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead…”
    Get full text
    Journal Article
  5. 5

    New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF by Holash, J, Wiegand, S J, Yancopoulos, G D

    Published in Oncogene (20-09-1999)
    “…Our analyses in several different tumor settings challenge the prevailing view that malignancies and metastases generally initiate as avascular masses that…”
    Get full text
    Journal Article
  6. 6

    Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development by Gale, N W, Yancopoulos, G D

    Published in Genes & development (01-05-1999)
    “…The term `vasculogenesis' refers to the earliest stages of vascular development, during which vascular endothelial cell precursors undergo differentiation,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury by Tanaka, M., Endo, S., Okuda, T., Economides, A.N., Valenzuela, D.M., Murphy, A.J., Robertson, E., Sakurai, T., Fukatsu, A., Yancopoulos, G.D., Kita, T., Yanagita, M.

    Published in Kidney international (01-01-2008)
    “…Once developed, end-stage renal disease cannot be reversed by any current therapy. Bone morphogenetic protein-7 (BMP-7), however, is a possible treatment for…”
    Get full text
    Journal Article
  11. 11

    Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands by Holland, Sacha J, Gale, Nicholas W, Mbamalu, Geraldine, Yancopoulos, George D, Henkemeyer, Mark, Pawson, Tony

    Published in Nature (London) (24-10-1996)
    “…Receptor tyrosine kinases of the EPH class have been implicated in the control of axon guidance and fasciculation, in regulating cell migration, and in…”
    Get full text
    Journal Article
  12. 12

    VEGF-initiated Blood-Retinal Barrier Breakdown in Early Diabetes by Qaum, Tamim, Xu, Qingwen, Joussen, Antonia M, Clemens, Mark W, Qin, Wenying, Miyamoto, Kazuaki, Hassessian, Haroutioun, Wiegand, Stanley J, Rudge, John, Yancopoulos, George D, Adamis, Anthony P

    “…The objectives of this study were to (1) determine whether endogenous vascular endothelial growth factor (VEGF) triggers diabetic blood-retinal barrier…”
    Get full text
    Journal Article
  13. 13

    Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis by Torres, R, Macdonald, L, Croll, S D, Reinhardt, J, Dore, A, Stevens, S, Hylton, D M, Rudge, J S, Liu-Bryan, R, Terkeltaub, R A, Yancopoulos, G D, Murphy, A J

    Published in Annals of the rheumatic diseases (01-10-2009)
    “…Monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) crystal-induced interleukin 1 beta (IL1beta) release contributes to inflammation in…”
    Get more information
    Journal Article
  14. 14

    Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice by Sleeman, M.W, Garcia, K, Liu, R, Murray, J.D, Malinova, L, Moncrieffe, M, Yancopoulos, G.D, Wiegand, S.J

    “…Obesity plays a central role in the development of insulin resistance and type 2 diabetes. We therefore examined the effects of a modified form of ciliary…”
    Get full text
    Journal Article
  15. 15

    Essential role for oncogenic Ras in tumour maintenance by Chin, Lynda, DePinho#, Ronald A, Tam, Alice, Pomerantz, Jason, Wong, Michelle, Holash, Jocelyn, Bardeesy, Nabeel, Shen, Qiong, O'Hagan, Ronan, Pantginis, Joe, Zhou, Hao, Horner, James W, Cordon-Cardo, Carlos, Yancopoulos, George D

    Published in Nature (London) (29-07-1999)
    “…Advanced malignancy in tumours represents the phenotypic end-point of successive genetic lesions that affect the function and regulation of oncogenes and…”
    Get full text
    Journal Article
  16. 16

    Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt by Rommel, Christian, Clarke, Brian A., Zimmermann, Sven, Nuñez, Lorna, Rossman, Roni, Reid, Kristina, Moelling, Karin, Yancopoulos, George D., Glass, David J.

    “…Extracellular signals often result in simultaneous activation of both the RafMEK-ERK and PI3K-Akt pathways (where ERK is extracellular-regulated kinase, MEK is…”
    Get full text
    Journal Article
  17. 17

    Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex by Croll, S.D., Suri, C., Compton, D.L., Simmons, M.V., Yancopoulos, G.D., Lindsay, R.M., Wiegand, S.J., Rudge, J.S., Scharfman, H.E.

    Published in Neuroscience (01-01-1999)
    “…Transgenic mice overexpressing brain-derived neurotrophic factor from the β-actin promoter were tested for behavioral, gross anatomical and physiological…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Increased Vascularization in Mice Overexpressing Angiopoietin-1 by Suri, Chitra, McClain, Joyce, Thurston, Gavin, McDonald, Donald M., Zhou, Hao, Oldmixon, Eben H., Sato, Thomas N., Yancopoulos, George D.

    “…The angiopoietins and members of the vascular endothelial growth factor (VEGF) family are the only growth factors thought to be largely specific for vascular…”
    Get full text
    Journal Article
  20. 20

    Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization by Asahara, Takayuki, Chen, Donghui, Takahashi, Tomono, Fujikawa, Koshi, Kearney, Marianne, Magner, Meredith, Yancopoulos, George D, Isner, Jeffrey M

    Published in Circulation research (10-08-1998)
    “…Angiopoietin-1 (Ang1) has been recently identified as the major physiological ligand for the tyrosine kinase receptor Tie2 and assigned responsibility for…”
    Get full text
    Journal Article